We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rate of Pelvic Inflammatory Disease at St. Michael's Hospital

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00783419
Recruitment Status : Completed
First Posted : October 31, 2008
Last Update Posted : April 25, 2016
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
A retrospective review of women who came through the ER at SMH with a pelvic inflammatory disease (PID) or tubo-ovarian abscess (TOA) between 1995-2005. They were looking at people with this diagnosis to determine how they were treated, whether as inpatient or outpatient and whether they were treated with drugs and how were these given and also did they develop an abscess.

Condition or disease
Pelvic Inflammatory Disease

Study Design

Study Type : Observational
Actual Enrollment : 55 participants
Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Rate of Pelvic Inflammatory Disease and Tubo-ovarian Abscess at SMH
Study Start Date : March 2007
Primary Completion Date : January 2010
Study Completion Date : January 2011

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women with pelvic-inflammatory disease or tubo-ovarian abscess
Criteria

Inclusion Criteria:

  • women admitted to Emergency with pelvic-inflammatory disease or tubo-ovarian abscess from the year range: 1995-2000

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00783419


Locations
Canada, Ontario
St. Michael's Hospital
Toronto, Ontario, Canada, M5B1W8
Sponsors and Collaborators
St. Michael's Hospital, Toronto
Investigators
Principal Investigator: Mark Yudin, MD St. Michael's Hospital, Toronto
More Information

Responsible Party: St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier: NCT00783419     History of Changes
Other Study ID Numbers: REB 07-042
First Posted: October 31, 2008    Key Record Dates
Last Update Posted: April 25, 2016
Last Verified: April 2016

Keywords provided by St. Michael's Hospital, Toronto:
tubo-ovarian abscess, pelvic-inflammatory disease

Additional relevant MeSH terms:
Pelvic Inflammatory Disease
Pelvic Infection
Infection
Adnexal Diseases
Genital Diseases, Female